Faculty and Staff Detail
|
William Spruill, Pharm.D., FASHP, FCCP Professor PCA Clinical Administrative Pharmacy |
| Contact Information | |
|---|---|
| Phone: | (706)542-5372 |
| Email: | bspruill@rx.uga.edu |
| Fax: | (706)542-5228 |
| Office: | 270 |
| Address: |
R.C. Wilson Pharmacy Building 250 Green Street UGA College of Pharmacy Athens, GA 30602-2354 |
| Biosketch | |||
|---|---|---|---|
| PharmD | Medical University of South Carolina | Charleston, SC | 1977 |
| ASHP Residency | Medical University of South Carolina | Charleston, SC | 1975 |
| BS Pharm | University of Georgia | Athens, GA | 1974 |
- Honors and Awards
- • Fellow, American Society of health-System Pharmacists
• Fellow, American College of Clinical Pharmacy
- Area of Expertise
- • Clinical Pharmacokinetics
• Outcomes Research
- Representative Publications
- DiPiro JT, Spruill WJ, Wade WE, Blouin RA, Pruemer JM. Concepts in Clinical
Pharmacokinetics: A Self-Instructional Course (fourth edition) 2006. American Society of Health Systems Pharmacist, Bethesda, MD
Wade WE, Spruill WJ, Leslie R. Cost analysis of fondaparinux versus preoperative and postoperative enoxaparin as venous thromboembolic event prophylaxis in elective hip replacement surgery. Am J Orthop. 2003:32 (4):201-205.
Spruill WJ, Wade WE, .Curricular and Content Survey of Clinical Pharmaokinetics Courses. Am. J Pharm Educ. 2003; 67(2) Article 16.
Spruill WJ, Burke SI, Wade WE, Taylor AT, Longe RL. A survey of the reasons pharmacists provide Pharmaceutical Care from both the patient and pharmacists perspective. J Soc Adm Pharm. 2003;20(6):213-218.
Spruill WJ, Wade WE, Leslie R. Determining institution specific costs of thromboembolic events using an algorithm and spreadsheet approach. Am J Health-Systems Pharm 2003; 60:1741-1749.
Spruill WJ, Wade WE. Cancer Awareness and Prevention Activities: Assessment of Pharmacist’s Knowledge and Interest. J Am Pharm Assoc 2004;44(1) 1-5.
Spruill WJ, Wade WE, Leslie R. A cost analysis of fondaparinux versus enoxaparin in total knee arthroplasty. Am J Ther 2004;11(1):3-8.
Wade WE, Spruill WJ, Leslie R. Cost analysis of fondaparinux versus enoxaparin as venous thromboembolism prophylaxis in hip fracture surgery. Am J Ther 2004;11(3):194-8.
Spruill WJ, Wade WE, Leslie R. Cost analysis of Fondaparinux vs enoxaparin as venous thromboembolism prophylaxis in elective hip replacement surgery. Blood Coagulation and Fibrinolysis 2004:, 15:1-5.
Wade WE, Spruill WJ, Leslie R. Cost analysis of fondaparinux versus enoxaparin as venous thromboembolism prophylaxis in hip fracture surgery. Am J Ther 2004; 11(3): 194-198.